Purpose: The purpose of this study is to determine what factors, in addition to a positive first trimester aneuploidy screen, correlate with a pregnant patient's decision to undergo invasive prenatal ...

Purpose: The study purpose was to examine the consequences of using dried blood spots rather than fresh sera in first-trimester Down syndrome screening. Methods: We collected and compared human ...

Screening for preeclampsia in the first trimester with the Fetal Medicine Foundation (FMF)’s model—which considers not only clinical characteristics but also additional factors like biomarkers and ...

Researchers provide a comprehensive overview of prenatal screening for fetal aneuploidies, including traditional serum screening, ultrasound imaging, and cell-free DNA testing. A 37-year-old pregnant ...

Study suggests more extensive screening method in the first trimester of pregnancy may improve detection of preeclampsia. A new screening algorithm for preeclampsia combining maternal history, ...

(HealthDay News) — The introduction of combined first-trimester screening correlated with an increase in chorionic villus sampling (CVS) and a decrease in amniocentesis, while both CVS and ...

A new screening algorithm for preeclampsia combining maternal history, ultrasound data and several tests for blood markers may better predict the majority of preeclampsia cases in the first trimester ...

They can reveal valuable health information about you and your baby, but some come with more considerations than others. Credit...Maggie Chiang Supported by By Emily Mullin This guide was originally ...

Please provide your email address to receive an email when new articles are posted on . Evidence remains consistent with past research supporting syphilis screening in pregnant people, the USPSTF said ...

HealthDay News — Third-trimester screening for alloimmunization in Rhesus c (Rhc)-negative women improves detection and treatment of hemolytic disease of the fetus and newborn (HDFN), according to a ...

AURORA, Colo. -- Among those at low-risk for preterm birth, a blood-based biomarker screening test during the second trimester identified pregnancies at higher risk for preterm birth, and a treatment ...